skip to content
 

Speakers (DAEW03)

Name Home Institution
A Atkinson
D Berry [MD Anderson Cancer Center]
B Bogachka [QMUL]
B Bornkamp [Novartis]
T Braun [Michigan]
F Bretz [Novartis]
M Campbell [Sheffield]
K Cheung [Columbia]
A Donner [Western Ontario]
V Dragalin [Aptiv Solutions, USA]
S Eldridge [QMUL]
V Fedorov [GSK]
N Flournoy [Missouri]
A Giovagnoli [Bologna]
P Goos [Antwerpen]
A Grieve [AptivSolutions]
H Grossmann [QMUL]
C Jennison [Bath]
Y Ji [.D. Anderson Cancer Center]
R Kessels Universiteit Antwerpen
K Kim [Wisconsin]
M Krams [Johnson & Johnson]
E Lancsar [Monash]
J Lee [MD Anderson Cancer Center]
S Leonov GlaxoSmithKline
J Louviere [U of Technology, Sydney]
L Moulton [Johns Hopkins]
B Mukherjee [Michigan]
B Neuenschwander Novartis Pharma AG
J Pinheiro [Johnson & Johnson]
L Pronzato [CNRS]
J Rose [U of Technology, Sydney]
B Rosenberger [George Mason]
M Ryan [Aberdeen]
M Savelieva Praz [Novartis]
C Taylor [Birmingham]
J Taylor [Michigan]
P Thall [M.D. Anderson Cancer Center]
SG Thompson [Cambridge]
H Thygesen [Lancaster]
P van de Ven [Vrije U, Amsterdam]
S-J Wang [FDA]
K Wathen [Johnson & Johnson]
C Weijer [Western Ontario]
I White [MRC]
University of Cambridge Research Councils UK
    Clay Mathematics Institute London Mathematical Society NM Rothschild and Sons